Evaluation of individualized medication under the guidance of genetic testing in the management of hypertension patients in rural areas
10.16462/j.cnki.zhjbkz.2019.10.024
- Author:
Xiao-li NI
1
;
Quan-qi TANG
;
Lun-lan LI
;
Sheng-quan ZHANG
Author Information
1. Nursing Department, Anhui First Affiliated Hospital of Anhui Medical University, Hefei 230000, China
- Publication Type:Research Article
- Keywords:
Gene test;
Family doctors contracted services;
Rural areas;
Essential hypertension
- From:
Chinese Journal of Disease Control & Prevention
2019;23(10):1284-1288
- CountryChina
- Language:Chinese
-
Abstract:
Objective This study combined genotyping with family doctors' contracting model to assess the application of precision medicine in rural patients with essential hypertension. Methods In this study, 209 hypertensive patients from 3 villages in Lujiang County, Hefei City, Anhui Province were selected as subjects and randomly divided into experimental group(n=105) and control group(n=104). The medication regimen of observation group was guided by genetic testing for gene sensitivity to antihypertensive drugs, and the control group was implemented routine pharmacy. All the patients were managed by family doctors. Adverse drug reaction rate, treatment compliance, blood pressure, body mass index (BMI), fasting blood glucose (FBG), cholesterol (TC), and triglycerides (TG) of the two groups were analyzed, respectively, during the 6-month intervention. Results After 6-month of intervention, the medication compliance of the experimental group were significantly higher than that of the control group, and the blood pressure and adverse drug reaction rate were significantly lower than that of the control group. After 3 months of intervention, there was no significant decrease in BMI, FBG, TC and TG in the two groups. After 6 months of intervention, the FBG, TC and TG of the experimental group were significantly decreased,while only the FBG value of the control group was significantly decreased. There were no significant changes in body mass index (BMI) values in both groups. Conclusions Individualized medication guided by genotyping can improve the treatment compliance, reduce the adverse drug reaction rate, and improve the treatment efficiency of patients with essential hypertension.
